11: p. 187. Schurgers, L.J., et al., Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood, 2007. 109(8): p. 3279-83. Packer, J.E., T.F. Slater, and R.L. Willson, Direct observation of a free radical interaction between vitamin E and vitamin C. Nature, 1979. 278(5706): p. 737-8. Carr, A.C. and S. Maggini, Vitamin C and Immune Function. Nutrients, 2017. 9(11). Burton, G.W.a.I., K.

Lancet 1(8632): 231-3. Hammarqvist, F., J. Wernerman, A. von der Decken and E. Vinnars (1990). Alanyl-glutamine counteracts the depletion of free glutamine and the postoperative decline in protein synthesis in skeletal muscle. Ann Surg 212(5): 637-44. Jiang, Z. M., J. D. Cao, X. G. Zhu, W. X. Zhao, J. C. Yu, E. L. Ma, X. R. Wang, M. W. Zhu, H. Shu and Y. W. Liu (1999).

Foram citados os principais efeitos colaterais e complicações, bem como as boas práticas para minimizar a chance de ocorrerem estas intercorrências.13 Referência bibliográfica ROGGENK MPER P. et al. Efficacy and safety of a new Botulinum toxin type A free of complexing proteins in the treatment of blepharospasm. Journal of Neural Transmission, v.113, p.303-312, 2006. BENECKE R. et al. A new Botulinum toxin type A free of complexing proteins for treatment of cervical dystonia. Neurology, v.64, p.

O glicinato férrico é o único composto totalmente sem sabor, com tecnologia taste-free , o que confere maior palatabilidade ao produto que o contém, auxiliando a aderência ao tratamento pelo público infantil.

Referência Bibliográfica: Fragasso, G et al: A Randomizes Clinical Trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure. Journal of the American College os Cardiology. Vol 48 n ,2006; 992 998.

(PE32583) Danchin N, et al. Efficacy Comparison of Trimetazidine with Therapeutic Alternatives in Stable Angina Pectoris: A Network Meta-Analysis. Cardiology 2011;120: 59 72 Fragasso, G et al: A Randomizes Clinical Trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure. Journal of the American College os Cardiology. Vol 48 n ,2006; 992-998.

Ophthalmol. 12 (2018) 839 848.doi:10.2147/OPTH.S163744. S.A. Alanazi, Y.S. Badawood, M.A. Aldawood, G.A. El-Hiti, A.M. Masmali, Effect of Refresh Plus preservative-free lubricant eyedrops on tear ferning patterns in dry eye and normal eye subjects, Clin. Ophthalmol. 13 (2019) 1011 1017. M. Diaz-Llopis, M.D. Pinazo-Duran, L. Diaz-Guiñon, M. Rahhal-Ortuño, M. Perez-Ramos, R. Bosch, R. Gallego-Pinazo, R.

Ann Allergy Asthma Immunol. 1998; 80(4):357-62. Petitpretz P. et al . Levofloxacin 500 mg once daily versus cefuroxime 250 mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis: clinical efficacy and exacerbation-free interval. Int J Antimicrob Agents. 2007; 30(1): 52-9. Habib MP. et al . Multicenter, randomized study comparing efficacy and safety of oral levofloxacin and cefaclor in treatment of acute bacterial exacerbations of chronic bronchitis [abstract].

Ann Allergy Asthma Immunol. 1998; 80(4):357 62. Petitpretz P. et al . Levofloxacin 500 mg once daily versus cefuroxime 250 mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis: clinical efficacy and exacerbation-free interval. Int J Antimicrob Agents. 2007; 30(1): 52 9. Habib MP. et al . Multicenter, randomized study comparing efficacy and safety of oral levofloxacin and cefaclor in treatment of acute bacterial exacerbations of chronic bronchitis [abstract].

Ann Allergy Asthma Immunol. 1998; 80(4):357-62. Petitpretz P. et al . Levofloxacin 500 mg once daily versus cefuroxime 250 mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis: clinical efficacy and exacerbation-free interval. Int J Antimicrob Agents. 2007; 30(1): 52-9. Habib MP. et al . Multicenter, randomized study comparing efficacy and safety of oral levofloxacin and cefaclor in treatment of acute bacterial exacerbations of chronic bronchitis [abstract].